Presence of serum anti-human T-lymphotropic virus type I (HTLV-I) IgM antibodies means persistent active replication of HTLV-I in HTLV-I-associated myelopathy
- 1 June 1991
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 103 (2) , 203-208
- https://doi.org/10.1016/0022-510x(91)90165-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Detection of specific sequences among DNA fragments separated by gel electrophoresisPublished by Elsevier ,2006
- HTLV-I associated myelopathy in an identical twinThe Lancet, 1990
- Rapid Development of Myelopathy after HTLV-I Infection Acquired by Transfusion during Cardiac TransplantationNew England Journal of Medicine, 1990
- Increased replication of HTLV‐I in HTLV‐I–associated myelopathyAnnals of Neurology, 1989
- Is anti-hbc IgM a useful clinical test in patients with HBsAg-positive chronic hepatitis or primary hepatocellular carcinoma?Hepatology, 1988
- Direct activation of resting T lymphocytes by human T-lymphotropic virus type INature, 1987
- Viral IgM antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and controlsActa Neurologica Scandinavica, 1987
- Chronic progressive myelopathy associated with elevated antibodies to human T‐lymphotropic virus type I and adult T‐cell leukemialike cellsAnnals of Neurology, 1987
- HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITYThe Lancet, 1986
- ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESISPublished by Elsevier ,1985